Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

BFRT in Adolescents After ACL Reconstruction

This is an interventional study that will examine effects of blood flow restriction training (BFRT) in adolescents aged 12-18 after anterior cruciate ligament reconstruction surgery (ACLR). The study aims to identify the effect of BFRT on quadriceps muscle strength and the patient's quality of life, and the overall tolerability of BFRT will be examined. Eight physical therapists at four sports medicine physical therapy (PT) sites will oversee all post-operative PT sessions. Subjects allocated to the BFR group will undergo BFRT, while control group will undergo standard-of-care ACLR rehabilitation, 2 days per week for 16 weeks. Measurements of strength, quality of life, and overall function will be completed at regular intervals.

Participants needed: 120
Trial details
Age: 12-18Biological sex: AllType: InterventionalSponsor: Children's Healthcare of AtlantaUpdated: Aug 2, 2021Locations: 1
Eligibility criteria

Adolescent male and female patients, age 12-18 [+4]

Skeletally immature patients with open growth plates, as determined via standard... [+8]

Status: Recruiting

Gabapentin Premedication to Reduce Postoperative Pain for Pediatric Tonsillectomy

The purpose of this pilot study: 1) to examine the use of gabapentin in reducing pain in the first 48 hours postoperatively including the total amount of narcotics mg/kg given 2) to record the time to first analgesic postoperatively and 3) to compare Wong Baker and the 0-10 numeric pain distress scale scores at 12, 24 and 48 hours postoperatively. We hypothesize one 15mg/kg (up to 600mg) dose of gabapentin will decrease mean narcotic amounts in mg/kg compared to participants who do not receive preoperative gabapentin and will demonstrate a decreased mean time to first analgesic as well as to lower mean pain scores for each age group at 12, 24 and 48 hours.

Participants needed: 50
Trial details
Phase: Phase 4Age: 3-18Biological sex: AllType: InterventionalSponsor: Children's Healthcare of AtlantaUpdated: Jul 24, 2019Locations: 1
Eligibility criteria

participants age 3-18 years [+3]

BMI >40kg/m2 [+3]